Clinical Trial Update: Incremental Hemodialysis: The TwoPlus Trial [NA]

View source ↗

Summary

The TwoPlus trial is currently recruiting to evaluate incremental hemodialysis in patients with end-stage kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Kidney Disease

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: End-Stage Kidney Disease | NA | Status: RECRUITING